Belpointe Asset Management’s ADC Therapeutics ADCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,724
Closed -$6.62K 3722
2022
Q4
$6.62K Buy
+1,724
New +$6.62K ﹤0.01% 2819